Cameron Reynolds

Mr. Cameron J.
Reynolds is a Manager at Volition Veterinary Diagnostics Development LLC, a Chief Executive Officer & Director at Volition Diagnostics UK Ltd., a President, Chief Executive Officer & Director at VolitionRX Ltd. and a Chief Executive Officer & Director at Hypergenomics Pte Ltd. He is on the Board of Directors at GlycanAge Ltd., Volition America, Inc., Path Education, Inc., Volition Diagnostics UK Ltd., VolitionRX Ltd., Hypergenomics Pte Ltd. and Belgian Volition SRL.
Mr. Reynolds was previously employed as an Independent Non-Executive Director by Wellfully Ltd., a Managing Director & Director by Mining House Ltd., a Commercialization Director by ProBio, Inc., a Regional Manager by South China Group Holdings Ltd., and a Chief Financial Officer by Aberdene Mines Ltd. He also served on the board at Pathify Holdings, Inc., Singapore Volition Pte Ltd., Atlantic Mining Plc, Carbon Mining Plc, Hunter Bay Resources, Inc., Iofina Natural Gas, Inc., KAL Energy, Inc., Magellan Copper & Gold Plc and Canyon Copper Corp.
He received his undergraduate degree from The University of Western Australia and an MBA from The University of Western Australia.